The FDA has approved atezolizumab combined with chemotherapy for treating stage III dMMR colon cancer, enhancing post-surgery treatment options.

Explore how biomarkers can predict BCG failure in high-risk bladder cancer, aiding in personalized treatment strategies.

A study suggests that a reduced dose of enfortumab vedotin may lower toxicity in older patients with urothelial carcinoma, ...

Explore a comparative study on ESR1 mutation testing using dPCR and NGS. Understand the strengths and applications of each ...

Learn how intelligent medical records enhance patient care, streamline workflows, and improve healthcare outcomes through ...

Explore the FDA fast track oncology drugs granted in September 2026, advancing treatments for various cancer types.

Recent headlines on leadership appointments, executive transitions and notable recognitions spotlight the leaders helping to ...